Approval · Notice of Compliance 17856 · 2016
SUNVEPRA: Notice of Compliance 17856
Issued March 9, 2016
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 17856
- Date
- March 9, 2016
- Company
- Bristol-Myers Squibb CanadaSt-Laurent, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| SUNVEPRA | 02452294 | Cancelled Post Market |
Medicinal ingredients
- ASUNAPREVIR 100 MG per CAP